Posaconazole hydrate
Based on 14 publication(s) in Google Scholar
Posaconazole hydrate is a broad-spectrum, second generation, triazole compound with antifungal activity.
For research use only. We do not sell to patients.
- CAS No.: 1198769-38-8
- Formula: C37H44F2N8O5
- Molecular Weight:718.79
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Posaconazole hydrate
More- Adv Funct Mater. 2025 May 9.
- Sci China Life Sci. 2022 Feb;65(2):341-361. [Abstract]
- Clin Chem. 2019 Dec;65(12):1522-1531. [Abstract]
- BMC Microbiol. 2025 Nov 5;25(1):715. [Abstract]
- Microchem J. 2026 Mar 27.
- Mol Pharm. 2022 Nov 7;19(11):4320-4332. [Abstract]
- Microbiol Spectr. 2025 May 6;13(5):e0318524. [Abstract]
- Drug Metab Dispos. 2025 Nov;53(11):100168. [Abstract]
- Med Mycol. 2018 Jun 1;56(4):452-457. [Abstract]
- Mycoses. 2022 Apr;65(4):458-465. [Abstract]
- Am J Cancer Res. 2021 Sep 15;11(9):4528-4540. [Abstract]
- J Mycol Med. 2022 Mar;32(1):101227. [Abstract]
- SSRN. 2026 Mar 7.
- Curr Res Virol Sci. 2022;3:100019. [Abstract]
-
Microbiological Assay
-
Microbiological Assay
All Parasite Isoforms
More
Biological Activity
Description
IC50 & Target
antifungal
In Vitro
Posaconazole has potent trypanocidal activity. Amiodarone acts synergistically with Posaconazole. Posaconazole also affects and disrupts Ca2+ homeostasis in T. cruzi. Posaconazole blocks the biosynthesis of ergosterol, which is essential for parasite survival. Posaconazole has a clear, dose-dependent effect on proliferation of the epimastigote (extracellular) stages, with a minimal inhibitory concentration of 20 nM and an IC50 of 14 nM. Against the clinically relevant intracellular amastigote form of the parasite, Posaconazole is even more potent. Posaconazole has the minimal inhibitory concentration and IC50 values of 3 nM and 0.25 nM[1]. Posaconazole is active against isolates of Candida and Aspergillus spp. that exhibit resistance to Fluconazole, Voriconazole, and Amphotericin B and is much more active than the other triazoles against zygomycetes[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. .
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1198769-38-8
-
Molecular Weight 718.79
-
Formula C37H44F2N8O5
-
SMILES
FC1=CC=C([C@@]2(CN3C=NC=N3)C[C@H](COC4=CC=C(N5CCN(C6=CC=C(N7C=NN([C@@H](CC)[C@H](C)O)C7=O)C=C6)CC5)C=C4)CO2)C(F)=C1.O
-
Synonyms
SCH56592 hydrate
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (14)
-
Journal Impact Factor
-
Most Recent
-
-
Sci China Life Sci
2022 Feb;65(2):341-361. PMID: 34047913 -
Clin Chem
Discovering Cross-Reactivity in Urine Drug Screening Immunoassays through Large-Scale Analysis of Electronic Health Records. [Abstract]2019 Dec;65(12):1522-1531. PMID: 31578215 -
BMC Microbiol
In vitro combination effects and mechanisms of Revaprazan with Triazole antifungal drugs on Aspergillus. [Abstract]2025 Nov 5;25(1):715. PMID: 41194018
Posaconazole hydrate purchased from MedChemExpress. Usage Cited in: BMC Microbiol. 2025 Nov 5;25(1):715. [Abstract]
When REV combined with POS, the inhibition zone of ΔAF-MFS32, ΔAF-MFS35 was significantly smaller than that of control group ΔAF-MFS27. REV: Revaprazan (8 µg/ml); POS: posaconazole (8 µg/ml).
Posaconazole hydrate purchased from MedChemExpress. Usage Cited in: BMC Microbiol. 2025 Nov 5;25(1):715. [Abstract]
Rhodamine 6G efflux pump activity. When the wild-type strain WT was used together with Posaconazole (POS, 0. 015–4 µg/mL) in REV and POS, the efflux pump activity was significantly enhanced compared with that of POS alone, which was statistically significant.
-
-
Mol Pharm
2022 Nov 7;19(11):4320-4332. PMID: 36269563 -
Microbiol Spectr
Synergistic antifungal activity of minocycline as an effective augmenting agent of fluconazole against drug-resistant Candida tropicalis. [Abstract]2025 May 6;13(5):e0318524. PMID: 40162832 -
Drug Metab Dispos
Metabolic flux analysis of bile acid biosynthesis acidic pathway in HepG2 cells reveals CYP8B1 inhibition of azole antifungals. [Abstract]2025 Nov;53(11):100168. PMID: 41124962 -
Med Mycol
2018 Jun 1;56(4):452-457. PMID: 29420769 -
Mycoses
COVID-19-associated pulmonary aspergillosis in ICU patients in a German reference centre: Phenotypic and molecular characterisation of Aspergillus fumigatus isolates. [Abstract]2022 Apr;65(4):458-465. PMID: 35138651 -
Am J Cancer Res
Repurposing of posaconazole as a hedgehog/SMO signaling inhibitor for embryonal rhabdomyosarcoma therapy. [Abstract]2021 Sep 15;11(9):4528-4540. PMID: 34659903 -
J Mycol Med
In vitro synergistic effect of minocycline combined with antifungals against Cryptococcus neoformans. [Abstract]2022 Mar;32(1):101227. PMID: 34800920 -
-
Curr Res Virol Sci
Identification of broad anti-coronavirus chemical agents for repurposing against SARS-CoV-2 and variants of concern. [Abstract]2022;3:100019. PMID: 35072124
Purity & Documentation
References
[1]. Benaim G, et al. Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole. J Med Chem. 2006 Feb 9;49(3):892-9. [Content Brief]
[2]. Sabatelli F, et al. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother. 2006 Jun;50(6):2009-15. [Content Brief]
[3]. Sansone-Parsons A, et al. Effect of a nutritional supplement on posaconazole pharmacokinetics following oral administration to healthy volunteers. Antimicrob Agents Chemother. 2006 May;50(5):1881-3. [Content Brief]
[4]. Veiga-Santos P, et al. Effects of amiodarone and posaconazole on the growth and ultrastructure of Trypanosoma cruzi. Int J Antimicrob Agents. 2012 Jul;40(1):61-71. [Content Brief]
[5]. Sun QN, et al. In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model. Antimicrob Agents Chemother. 2002 Jul;46(7):2310-2. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)